retatrutide eli lilly press release 2024 2025 Lilly's triple-acting obesity drug hits goal in Phase 3 trial Lilly's triple agonist, retatrutide, delivered
Description
Neben der blutzuckersenkenden Wirkung beeinflusst Semaglutid das Zentralnervensystem und reduziert das Hungergefhl, was zur Gewichtsreduktion beitrgt
Ive never looked back
There were people who didnt want to see their stock price go down if something went wrong
Green J, Bethel M, Armstrong P et al
Blood sugar control : Significant reductions in HbA1c levels, showing better control of blood sugar
